Profiling And Treatment Patterns In Nsclc Patients With Cns (Brain) Metastases In Europe And Asia.

JOURNAL OF CLINICAL ONCOLOGY(2018)

引用 2|浏览4
暂无评分
摘要
e21085Background: Between 25% and 40% of NSCLC patients develop CNS metastases, a high unmet medical need with median survivals of 3–14 months. Using a large oncology real-world patient database, w...
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要